281 related articles for article (PubMed ID: 7892130)
41. [Pylethrombosis following splenectomy (author's transl)].
Aufschnaiter M; Salzer GM
MMW Munch Med Wochenschr; 1981 Oct; 123(40):1503-5. PubMed ID: 6795460
[TBL] [Abstract][Full Text] [Related]
42. Splenectomy for massive splenomegaly: long-term results and risks for mortality.
Taner T; Nagorney DM; Tefferi A; Habermann TM; Harmsen WS; Slettedahl SW; Donohue JH
Ann Surg; 2013 Dec; 258(6):1034-9. PubMed ID: 23222031
[TBL] [Abstract][Full Text] [Related]
43. Splenectomy in myeloid metaplasia.
Cabot EB; Brennan MF; Rosenthal DS; Wilson RE
Ann Surg; 1978 Jan; 187(1):24-30. PubMed ID: 74243
[TBL] [Abstract][Full Text] [Related]
44. [Splenic extramedullary hematopoiesis in myelofibrosis. Pathogenetic considerations apropos of a personally studied case].
Piaserico PL; Piaserico GP
Minerva Med; 1983 Oct; 74(39):2313-8. PubMed ID: 6657100
[TBL] [Abstract][Full Text] [Related]
45. Laparoscopic splenectomy is a safe and effective procedure for patients with splenomegaly due to portal hypertension.
Hama T; Takifuji K; Uchiyama K; Tani M; Kawai M; Yamaue H
J Hepatobiliary Pancreat Surg; 2008; 15(3):304-9. PubMed ID: 18535769
[TBL] [Abstract][Full Text] [Related]
46. Related donor marrow transplant for chronic myeloid leukemia: patient characteristics predictive of outcome.
Enright H; Daniels K; Arthur DC; Dusenbery KE; Kersey JH; Kim T; Miller WJ; Ramsay NK; Vercellotti GM; Weisdorf DJ; McGlave PB
Bone Marrow Transplant; 1996 Apr; 17(4):537-42. PubMed ID: 8722351
[TBL] [Abstract][Full Text] [Related]
47. [Indications for splenectomy in the anemic forms of myelofibrosis with myeloid metaplasia of the spleen].
Dechavanne M; Viala JJ; Barbier Y; Revol L
Sem Hop; 1972 Apr; 48(17):1187-92. PubMed ID: 4342370
[No Abstract] [Full Text] [Related]
48. Splenectomy for agnogenic myeloid metaplasia.
Gomes MR; Silverstein MN; Remine WH
Surg Gynecol Obstet; 1967 Jul; 125(1):106-8. PubMed ID: 6026679
[No Abstract] [Full Text] [Related]
49. [Splenectomy for hematologic disease in patients over 70 years of age. Apropos of 38 cases].
Letoquart JP; La Gamma A; Kunin N; Chaperon J
J Chir (Paris); 1995; 132(6-7):295-8. PubMed ID: 7499451
[TBL] [Abstract][Full Text] [Related]
50. Granulomatous inflammation in splenectomy specimens. Clinicopathologic study of 20 cases.
Kuo T; Rosai J
Arch Pathol; 1974 Oct; 98(4):261-8. PubMed ID: 4472126
[No Abstract] [Full Text] [Related]
51. Fine-needle aspiration biopsy and flow cytometry immunophenotyping of lymphoid and myeloproliferative disorders of the spleen.
Zeppa P; Picardi M; Marino G; Troncone G; Fulciniti F; Vetrani A; Rotoli B; Palombini L
Cancer; 2003 Apr; 99(2):118-27. PubMed ID: 12704692
[TBL] [Abstract][Full Text] [Related]
52. [Splenectomy in a large general hospital: often caused by iatrogenic injury, often causing multiple complications; poor adherence to post-operative guidelines for vaccination and prophylaxis].
Brandenburg JJ; de Jong VM; Oostenbroek RJ; Westenend PJ; Frenay HM; Hesp WL; Plaisier PW
Ned Tijdschr Geneeskd; 2008 May; 152(20):1164-8. PubMed ID: 18549143
[TBL] [Abstract][Full Text] [Related]
53. Trends in laparoscopic splenectomy for massive splenomegaly.
Grahn SW; Alvarez J; Kirkwood K
Arch Surg; 2006 Aug; 141(8):755-61; discussion 761-2. PubMed ID: 16924082
[TBL] [Abstract][Full Text] [Related]
54. Outcome of total splenectomy with portosystemic shunt for massive splenomegaly and variceal bleeding in cystic fibrosis.
Robberecht E; Van Biervliet S; Vanrentergem K; Kerremans I
J Pediatr Surg; 2006 Sep; 41(9):1561-5. PubMed ID: 16952592
[TBL] [Abstract][Full Text] [Related]
55. The role of splenectomy in myelofibrosis with myeloid metaplasia.
Barugola G; Cavallini A; Lipari G; Armatura G; Mantovani W; Baggio E
Minerva Chir; 2010 Dec; 65(6):619-25. PubMed ID: 21224796
[TBL] [Abstract][Full Text] [Related]
56. Surgical and radiotherapeutic approaches for myelofibrosis with myeloid metaplasia.
Mesa RA; Tefferi A
Semin Oncol; 2005 Aug; 32(4):403-13. PubMed ID: 16202686
[TBL] [Abstract][Full Text] [Related]
57. Autoimmune haemolytic anaemia as the presenting manifestation of agnogenic myeloid metaplasia.
Mohite U; Pathare A; al Kindi S; Hiwase D; Vadakkepat N; Knox-Macaulay H
Haematologia (Budap); 2002; 32(4):495-9. PubMed ID: 12803124
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of splenomegaly in the hepatosplenic form of mansonic schistosomiasis.
Maia MD; Lopes EP; Ferraz AA; Barros FM; Domingues AL; Ferraz EM
Acta Trop; 2007 Mar; 101(3):183-6. PubMed ID: 17336262
[TBL] [Abstract][Full Text] [Related]
59. Redefining the role of splenectomy in patients with idiopathic splenomegaly.
Pottakkat B; Kashyap R; Kumar A; Sikora SS; Saxena R; Kapoor VK
ANZ J Surg; 2006 Aug; 76(8):679-82. PubMed ID: 16916382
[TBL] [Abstract][Full Text] [Related]
60. Effect of splenectomy on teardrop-shaped erythrocytes in agnogenic myeloid metaplasia.
DiBella NJ; Silverstein MN; Hoagland HC
Arch Intern Med; 1977 Mar; 137(3):380-1. PubMed ID: 843155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
